Literature DB >> 3004973

SV40 enhancer activation during retinoic acid-induced differentiation of F9 embryonal carcinoma cells.

M J Sleigh, T J Lockett.   

Abstract

The transient expression vector pSV2CAT, which carries the bacterial chloramphenicol acetyl transferase (CAT) gene under the control of the SV40 early promoter, was used to transfect the murine embryonal carcinoma cell line F9 at various times during the retinoic acid-induced differentiation of these cells. Expression of the CAT gene under SV40 promoter control was found to increase markedly on F9 cell differentiation, measured relative to expression from the thymidine kinase promoter in the same cells. A series of constructs was prepared to identify the features of the SV40 early promoter required for transcription in differentiated and undifferentiated cells, as well as the factors limiting transcription in each case. The increased transcription seen on F9 cell differentiation was not observed when cells were transfected with molecules lacking a functional enhancer. It appears that as embryonal carcinoma cells differentiate, increased SV40 transcription results from enhancer sequence activation. In both differentiated and undifferentiated cell types the level of transcription was found to be limited by the availability and/or activity of cellular factors necessary for enhancer function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004973      PMCID: PMC554738          DOI: 10.1002/j.1460-2075.1985.tb04155.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

2.  Virus infection of murine teratocarcinoma stem cell lines.

Authors:  N M Teich; R A Weiss; G R Martin; D R Lowy
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

3.  Adenovirus E1a proteins repress transcription from the SV40 early promoter.

Authors:  A Velcich; E Ziff
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

4.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

5.  Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cells.

Authors:  M J Rosenstraus; A J Levine
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

6.  Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells.

Authors:  S Segal; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?

Authors:  M B Oldstone; A Tishon; F J Dutko; S I Kennedy; J J Holland; P W Lampert
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  Resistance of teratocarcinoma stem cells to infection with simian virus 40: early events.

Authors:  D E Swartzendruber; T D Friedrich; J M Lehman
Journal:  J Cell Physiol       Date:  1977-10       Impact factor: 6.384

9.  Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells.

Authors:  A Pellicer; E F Wagner; A el-Kareh; M J Dewey; A J Reuser; S Silverstein; R Axel; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  Stable transformation of mouse teratocarcinoma stem cells with the dominant selective marker Eco.gpt and retention of their developmental potentialities.

Authors:  D Bucchini; C Lasserre; F Kunst; R Lovell-Badge; R Pictet; J Jami
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  20 in total

1.  The SV40 early transcriptional regulatory element is unable to direct gene expression in pituitary GH-3 cells.

Authors:  T A Coleman; Y T Hou; J J Kopchick
Journal:  Gene Expr       Date:  1992

2.  Adenovirus E1A-mediated negative control of genes activated during F9 differentiation.

Authors:  K S Young; R Weigel; S Hiebert; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

3.  Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.

Authors:  D R Hurwitz; R Hodges; W Drohan; N Sarver
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

5.  Transcriptional selectivity in early mouse embryos: a qualitative study.

Authors:  C Bonnerot; M Vernet; G Grimber; P Briand; J F Nicolas
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

6.  CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity.

Authors:  B T Lamb; K Satyamoorthy; L Li; D Solter; C C Howe
Journal:  Gene Expr       Date:  1991

7.  The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.

Authors:  N B La Thangue; B Thimmappaya; P W Rigby
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

8.  Defective expression of adenovirus genes during early infection of undifferentiated OTF963 embryonal carcinoma cells.

Authors:  C C Nelson; A W Braithwaite; M Silvestro; A J Bellett
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  Differential regulation of viral and cellular genes in F9 mouse embryonal carcinoma cells.

Authors:  M J Sleigh
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

10.  Cell-specific activity of the constituent elements of the simian virus 40 enhancer.

Authors:  H Nomiyama; C Fromental; J H Xiao; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.